Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00006103
What this trial is testing

Combination Chemotherapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 400
Not applicableStudy completedNCT00410579
What this trial is testing

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Who this might be right for
Colorectal CancerFatigueLong-term Effects Secondary to Cancer Therapy in Adults+2 more
NSABP Foundation Inc 744
Testing effectiveness (Phase 2)Study completedNCT00381862
What this trial is testing

Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX

Who this might be right for
Colorectal CancerNausea and Vomiting
OHSU Knight Cancer Institute 54
Early research (Phase 1)Study completedNCT00631410
What this trial is testing

Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT01524094
What this trial is testing

Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

Who this might be right for
Colorectal Peritoneal Carcinomatosis
Uppsala University 49
Early research (Phase 1)Ended earlyNCT01238965
What this trial is testing

Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
University of Southern California 7
Large-scale testing (Phase 3)Study completedNCT00769405
What this trial is testing

Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer

Who this might be right for
Colorectal CancerPrimary Peritoneal Cavity Cancer
UNICANCER 264
Testing effectiveness (Phase 2)Study completedNCT00020917
What this trial is testing

Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT00040820
What this trial is testing

Oxaliplatin in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Roswell Park Cancer Institute
Not applicableUnknownNCT01671891
What this trial is testing

Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer

Who this might be right for
Rectal Cancer
Fudan University 100
Testing effectiveness (Phase 2)UnknownNCT02288078
What this trial is testing

Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

Who this might be right for
Rectal Cancer
Clinical Research Support Center Kyush 74
Testing effectiveness (Phase 2)Study completedNCT00411450
What this trial is testing

Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+4 more
Amgen 116
Early research (Phase 1)Study completedNCT01765790
What this trial is testing

Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors

Who this might be right for
Metastatic Adenocarcinoma of the Colon or RectumMalignant Solid Tumors
Baxalta now part of Shire 68
Not applicableNot Yet RecruitingNCT07406126
What this trial is testing

Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastases (CRCLM)Unresectable Colorectal Liver Metastases
Fernando Gómez Muñoz 30
Not applicableStudy completedNCT02781935
What this trial is testing

Diffusion-Weighted MRI for Liver Metastasis

Who this might be right for
Colorectal CancerColon Cancer Liver MetastasisMalignant Neoplasm of Rectum Metastatic to Liver
European Organisation for Research and Treatment of Cancer - EORTC 233
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07383285
What this trial is testing

CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and Tuvonralimab as First-line Treatment for RAS-Mutant/MSS Metastatic Rectal Cancer

Who this might be right for
Rectal Neoplasms Malignant
Peking University Cancer Hospital & Institute 106
Very early researchActive Not RecruitingNCT03164486
What this trial is testing

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

Who this might be right for
Breast CarcinomaColorectal CarcinomaLung Carcinoma+5 more
Julie L. Sutcliffe, Ph.D 27
Early research (Phase 1)Study completedNCT03871959
What this trial is testing

Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma

Who this might be right for
Adenocarcinoma of the PancreasAdenocarcinoma of the ColonAdenocarcinoma of the Rectum
Centre Leon Berard 54
Testing effectiveness (Phase 2)Study completedNCT00077298
What this trial is testing

Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT04963283
What this trial is testing

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

Who this might be right for
Colorectal AdenocarcinomaColon CancerColon Adenocarcinoma+4 more
University of Colorado, Denver 48
Next Page